drugset / Trial / NCT04353336

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

NCT04353336

Phase 2/3 Completed 194 enrolled Tanta University
RandomizedParallel-groupOpen-labelTreatment

Summary

Chloroquine or hydroxychloroquine in COVID-19 treatment

Timeline

Start
2020-03-23
Primary completion
2020-06-01
Completion
2020-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule
Subject Hydroxychloroquine Small molecule

Indications